Zymework spurns All Blue Capital’s $773m takeover bid
Zymeworks' board of directors has rejected an unsolicited, non-binding acquisition offer from an affiliate of UK-based All Blue Capital.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
